JP Stock MarketDetailed Quotes

4536 Santen Pharmaceutical

Watchlist
  • 1442.5
  • 0.00.00%
20min DelayMarket Closed Mar 21 15:30 JST
493.41BMarket Cap19.93P/E (Static)

Santen Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Santen Pharmaceutical Q3 2025 Earnings Date

Currency：JPYFeb 6, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
76.37B
--
-0.85%
EPS
--
25.24
--
+22.17%
Analyst Rating
Buy

Mar 11, 2025

Santen Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 72.000B--
May 13, 20252025/Q4-- / 81.128B--
Feb 6, 20252025/Q376.369B / 75.285B--
Nov 7, 20242025/Q271.633B / 74.047B--
Aug 6, 20242025/Q174.771B / 73.939B--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q1-- / 72.000B--
May 13, 20252025/Q4-- / 81.128B--
Feb 6, 20252025/Q376.369B / 75.285B--
Nov 7, 20242025/Q271.633B / 74.047B--
Aug 6, 20242025/Q174.771B / 73.939B--

Unlock Free Earnings Estimates

Santen Pharmaceutical Earnings Reports

  • Santen Pharmaceutical: Notice regarding revisions to dividend forecasts

    Feb 6 01:00 ET

  • Santen Pharmaceutical: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [IFRS] (consolidated)

    Feb 6 01:00 ET

  • Santen Pharmaceutical: Confirmation letter

    Nov 11, 2024 01:32 ET

  • Santen Pharmaceutical: Half-Yearly Report - Term 113 (2024/04/01 - 2025/03/31)

    Nov 11, 2024 01:30 ET

    • Read more

    Market Insights

    Market Hot Picks Market Hot Picks
    No. Symbol Price
    JX Advanced Metals
    5016
    958
    Metaplanet
    3350
    4730
    Mitsubishi UFJ Financial Group
    8306
    2226.0
    4
    Nippon Telegraph & Telephone
    9432
    149.0
    5
    Mitsubishi Heavy Industries
    7011
    2874.5
    Log In for the Full List
    Unlock Now